Efstathios Koutsostathis*

Sotiria Hospital, Greece

*Corresponding Author: Efstathios Koutsostathis, Sotiria Hospital, Greece.

Received: November 23, 2022; Published: December 16, 2022

Abstract

Osteoporosis: Osteoporosis is a systemic disease that affects the skeleton and is characterised by reduced bone mass and deterioration of the bone structure. The direct consequence is increase in bone fragility, resulting in fractures even with little mechanical force. It is the most common complication of metabolic bone diseases. Simply put, osteoporosis is a systemic disease marked by increased incidence of fractures [1,2].

Osteoporosis is roughly divided into idiopathic and secondary. Idiopathic osteoporosis is further divided into type I and type II osteoporosis. These two types were previously known as postmenopausal and senile osteoporosis respectively [3].

Keywords: Osteoporosis; Menopause; Fragility

References

1. “Consensus Development Conference Diagnosis, prophylaxis and treatment of osteoporosis”. The American Journal of Medicine 94 (1993): 646-650.
2. Cummings SR and Melton LJ. “Osteoporosis I: Epidemiology and outcomes of osteoporotic fractures”. Lancet 9319 (2002): 1761-1767.
3. Riggs BL., et al. “Differential changes in bone mineral density of the appendicular and axial skeleton with aging: Relationship to spinal osteoporosis”. Journal of Clinical Investigation 67 (1981): 328-335.
4. Ηiller TA., et al. “Height loss in older women: Risk of hip fracture and mortality independent of vertebral fractures”. Journal of Bone and Mineral Research 27 (2012): 153-159.
5. Court-Brown CM and Caesar B. “Epidemiology of adult fractures: A review”. Injury 37 (2006): 691-697.
6. Μundy G. “Pathogenesis of osteoporosis and challenges for drug delivery”. Advanced Drug Delivery Reviews 42 (2000): 165-17355.
7. Elizabeth Culotta and Daniel E Koshland Jr. “NO news is good news. 9nitric oxide; includes information about other significant advances and discoveries of 1992) (Molecule of the Year)”. Science 258 (5090): 1862-186455) Elizabeth Culotta and Daniel E. Koshland Jr (1992). “NO news is good news”. 9nitric oxide; ear)”. Science5090 (1992): 1862-1864.
8. Anjani Manocha., et al. “Lead as a risk factor for osteoporosis in post-menopausal women”. Indian Journal of Clinical Biochemistry Sept (2017).
9. Reyes-Hinojosa D., et al. Environmental Toxicology and Pharmacology 72 (2019): 103219.
10. Michalis Leotsinidis. “Levels of concentrations of lead, cadmium, chromium, nickel, zinc, copper in the hair of a semi-urban population of the NW Peloponnese, University of Patras, School of Health Sciences”. Department of Medicine (1990).
11. Jesus M Lavado-García., et al. “Dietary Intake of Cadmium, Lead and Mercury and Its Association with Bone Health in Healthy Premenopausal Women”. International Journal of Environmental Research and Public Health 12 (2017): 1437.
12. Edwin Aihanuwa Uwagie‐Ero., et al. “Osteocyte viability and bone density in cadmium chloride‐induced osteoporosis ameliorated with Pilostigma thonningii stem bark‐extracted D‐3‐O‐methy‐chiroinositol”. Animal Models and Experimental Medicine 1 (2019): 25-33.
13. Angelo Licata., et al. “Osteoporosis clinical updates, clinical information for health care professionals”. Fall (2013).
14. “Aluminum toxicity to bone: A multisystem effect?” Gordon L. Klein Οsteoporosis and sarcopenia 5 (2019) 2-9.
15. National Institute of Health (substance profiles): "2,3,7,8-Tetrachlorodibenzo-p-Dioxin (TCDD); "Dioxin" CAS No. 1746-01-6.
16. Commoner B (Greens.org): "The Political History of Dioxin".
17. World Health Organization: "Dioxins and their effects on human health" (Fact Sheet No 225, May 2010).
18. Junichi Fukushia., et al. “Effects of dioxin-related compounds on bone mineral density inpatients affected by the Yusho incident”. Chemosphere 145 (2016): 25-33.
19. Sun Singh., et al. “Inhibition of dioxin effects on bone formation in vitro by a newly described aryl hydrocarbon receptor antagonist, resveratrol”. Journal of Endocrinology1 (2000): 183-195.
20. Darrell R Boverhof., et al. “Dioxin Induces an Estrogen-Like, Estrogen Receptor-Dependent Gene Expression Response in the Murine Uterus”. Μοlecular Pharmacology May 69.5 (2006): 159901606.

Citation

Citation: Efstathios Koutsostathis. “Trace Elements and Bone Metabolism”.Acta Scientific Medical Sciences 7.1 (2023): 54-59.

Copyright

Copyright: © 2022 Efstathios Koutsostathis. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.